Latest Insights on TELL
Micron’s Unbearable Earnings, Pay-To-Play FDA & Peloton Needs Dick’s September 30, 2022 Great Stuff
Friday Four Play: The “Bearish Exhaustion?” Edition Great Ones, I don’t like to give y’all false hope, but Micron Technology (Nasdaq: ) just continued a trend I’ve noticed building on Wall Street lately. That trend? A company issues pretty bad news, but the stock rallies anyway. In the sentiment analysis business, we call this an […]
Changing Up the Playbook (First Put of the Year) September 30, 2022 Investing, King's Corner, Trading Strategies, Unusual Options Activity
It’s been a rocky Q3 for the stock market… The S&P 500 hit a new YTD low this morning. So, what’s a trader to do?
The Biggest Volatility Myth? September 30, 2022 Investing, Investment Opportunities, Real Talk, Stocks
This is the price you pay for high returns. 
Apple’s Appealing Advantage, Not So RAD & Beyond’s Crazy September 29, 2022 Great Stuff
These Apples Are Delicious? As a matter of fact, they are, Great Ones. Can all this fruit be free? Unfortunately, no. Apple (Nasdaq: ) is not free. But AAPL stock is down about 20% so far this year, so we’ve got that going for us … which is nice? Well, for bargain hunters at least. […]
Biogen’s Alzheimer’s All-Timer, Thor Thunders On, Cowardly Lionsgate September 28, 2022 Great Stuff
Biogen’s Redemption Song Great Ones, so this ain’t the end, I saw Biogen (Nasdaq: ). Today, I had to turn my heart away. The news smelled like the sun, BIIB for everyone. And tales … it never fails. I’ve been lying so low in the weeds that Biogen’s latest Alzheimer’s drug ambushed me. It’s got […]MEET OUR EXPERTS
Editor of Alpha Investor
Research Analyst
Director of VIP Services
Chief Investment Strategist of Money & Markets
Editor of Strategic Fortunes and three elite services
